Novel adipokines: methodological utility in human obesity research (Q40292640)

19 September 2017

Novel adipokines: methodological utility in human obesity research (English)

1 reference

19 September 2017

0 references

4

1 reference

19 September 2017

F Eichelmann

1

0 references

Krasimira Aleksandrova

object named as

K Aleksandrova

7

0 references

Heiner Boeing

6

object named as

H Boeing

1 reference

19 September 2017

N Rudovich

2

1 reference

19 September 2017

A F Pfeiffer

3

1 reference

19 September 2017

R D Giuseppe

5

1 reference

19 September 2017

language of work or name

English

0 references

publication date

15 March 2017

1 reference

International Journal of Obesity

19 September 2017

1 reference

19 September 2017

41

1 reference

19 September 2017

976-981

1 reference

19 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/ijo.2017.68

19 September 2017

0 references

cites work

Body-Mass Index and Mortality among 1.46 Million White Adults

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

Innate immunity modulates adipokines in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

Adipokines in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

The role of adipokines in chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

Adiponectin, Adipokines, and the Need for Long-Term Human Studies With Comprehensive End Points.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

EPIC-Germany--A source for studies into diet and risk of chronic diseases. European Investigation into Cancer and Nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

Validity of a short questionnaire to assess physical activity in 10 European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

Metabolic functions of FABPs--mechanisms and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

Mechanism and clinical evidence of lipocalin-2 and adipocyte fatty acid-binding protein linking obesity and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

CCL2-CCR2 Signaling in Disease Pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

Biological variation of established and novel biomarkers for atherosclerosis: Results from a prospective, parallel-group cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

The role of progranulin in diabetes and kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

Serum vaspin concentrations in human obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

Plasma Procalcitonin Is Associated with Obesity, Insulin Resistance, and the Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

Inflammation, metabolism and adipokines: toward a unified theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

7 January 2021

Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

7 January 2021

Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

7 January 2021

Reliability of tumor markers, chemokines, and metastasis-related molecules in serum.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2017.68

7 January 2021

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28293019

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/IJO.2017.68

1 reference

19 September 2017

1 reference